Q4 2023 Summit Therapeutics Inc Earnings Call Transcript
Hello, everyone. First and foremost, we'd like to apologize for the delay of this event.
Good morning, and welcome to Summit Fourth Quarter and Year End 2023 earnings call. All participants, all participants will be able to will be able to listen only until the question-and-answer portion of this call. We do not expect any technical difficulties today for worried However, in the event that we lose the webcast connection and we are unable to provide any updates, lease rate up to 10 minutes for resolution, please refer to the company's website for updates. Please note that today's call is being recorded. (Operator Instructios)
At this time, I would like to turn the call over to Dave Gancarz, Summit Therapeutics, Chief Business and Strategy Officer. You may now proceed, please.
Good morning, and thank you for joining us. Our press release was issued earlier this morning and is available on the homepage of our website. Our Forms 10K and S. three were also filed
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |